Ep. Brass et al., Decreased NADH dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial disease, AM J P-HEAR, 280(2), 2001, pp. H603-H609
Citations number
41
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Peripheral arterial disease (PAD) is associated with muscle metabolic chang
es that may contribute to the disability in these patients. However, the bi
ochemical defects in PAD have not been identified. The present study was un
dertaken to test the hypothesis that PAD is associated with specific defect
s in skeletal muscle electron transport chain activity. Seventeen patients
with PAD and nine age-matched controls underwent gastrocnemius muscle biops
ies. There were no differences in the mitochondrial content per gram of ske
letal muscle as assessed by citrate synthase activity between the PAD patie
nts and the control subjects. Skeletal muscle NADH dehydrogenase activity w
as decreased by 27% compared with controls when expressed per unit of citra
te synthase activity. Expression of enzyme activities normalized to cytochr
ome c-oxygen oxidoreductase activity confirmed a 26% decrease in NADH dehyd
rogenase activity and also demonstrated a 38% decrease in ubiquinol-cytochr
ome c oxidoreductase activity. Thus PAD is associated with specific changes
in muscle mitochondrial electron transport chain activities characterized
by relative decreases in NADH dehydrogenase and ubiquinol-cytochrome c oxid
oreductase activities, which may contribute to the metabolic abnormalities
and decreased exercise performance in these patients.